ConductScience.org, home

Gene86

ACTL6A: actin like 6A

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. ACTL6A: actin like 6A. Genes, record 86. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/86

FollowSave as evidence

Gene

Symbol
ACTL6A
HGNC
Name
actin like 6A
HGNC
NCBI Gene ID
86
NCBI Gene
HGNC ID
HGNC:24124
HGNC
Ensembl
ENSG00000136518
NCBI Gene
Aliases
ACTL6, ARPN-BETA, Actl6, Arp4, BAF53A, Baf53a, INO80K, SMARCN1
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
O96019Actin-like protein 6A42925Ensembl, GeneID, HGNC

Source UniProt

Patents25

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4650780 A22025-11-1912854O96019Espacenet
JP 2025164846 A2025-10-3024O96019Espacenet
JP 2025517970 A2025-06-1212854O96019Espacenet
JP 2025062604 A2025-04-141553O96019Espacenet
US 11446398 B22022-09-201553O96019Espacenet
JP 2022524081 A2022-04-27104524O96019Espacenet
US 11078247 B22021-08-03163O96019Espacenet
WO 2021132592 A2021-07-0174O96019Espacenet
US 9878056 B22018-01-30906O96019Espacenet
JP 2017141230 A2017-08-174974O96019Espacenet

See all 25 patents

NIH grants989

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleACTL6A papersNewest fiscal year
P30CA008748Cancer Center Support Grant122025
R01CA113794The function of Snf5 (SMARCB1), an epigenetic tumor suppressor102025
R01CA163915ATP-Dependent Chromatin Remodeling in Human Malignancy92025
R01CA172152Role of the SWI/SNF complex in tumor suppression92025
ZIAES071006Epigenetic and Transcriptional Functions of Nuclear Receptors and Chromatin Remodeling Proteins in Stem and Cancer Cells72025
P30CA016672Cancer Center Support Grant52025
P01CA092584Structural Cell Biology of DNA Repair Machines42025
P30CA125123Baylor College of Medicine Cancer Center - Cancer Center Support Grant42025
R01AG011085Ubiquitin‐mediated proteolysis and cell cycle control42025
P30CA016087Cancer Center Support Grant32025

Source NIH's project files

See all 989 nih grants

Papers989

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Overexpression of ACTL6A is associated with poor prognosis in gastric cancer, and nuclear level is an independent predictor.Transl Cancer Res202642180885PubTator, text miningPubMed
p63 in skin homeostasis and disease: molecular mechanisms and therapeutic potentials.Cell Death Discov202641876478PubTator, text miningPubMed
Recognition and remodelling of nucleosomes and hexasomes by the human INO80 complex.Nucleic Acids Res202641775336PubTator, text miningPubMed
PROTAC-based protein degradation: a window of opportunity for melanoma therapy.J Biomed Sci202641761284PubTator, text miningPubMed
Actin-related protein 6 regulates the Hedgehog signaling pathway: Molecular basis for stemness maintenance of hepatoma cells.Cytojournal202641743751PubTator, text miningPubMed
TRKB-based signature identifies high-risk squamous cell carcinoma cases and TRKB blockade reprograms tumor and stromal cells toward suppressive phenotypes.J Biomed Sci202641742188PubTator, text miningPubMed
WWC proteins as emerging biomarkers and therapeutic targets in cancer pathogenesis.Front Cell Dev Biol202641727322PubTator, text miningPubMed
SWI/SNF Chromatin Remodelling Complex in Hepatic Physiology: Mechanistic Insights Into Development, Homeostasis and Pathogenesis.J Cell Mol Med202641578412PubTator, text miningPubMed
Dated gene duplications elucidate the evolutionary assembly of eukaryotes.Nature202641339551PubTator, text miningPubMed
ACTL6A accelerates the progression of NSCLC through hippo/YAP signaling axis and TAMs-mediated immune regulation.Int Immunopharmacol202641223612PubTator, text miningPubMed

See all 989 papers

None in this release

  • Drugs
  • Trials

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/86

GET https://conductscience.org/api/genes/v1/86/patents?page=2